Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.35 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7977844 | 1.00 | TSHR (0.35) | TSHRMEN1KMT2ACYP2D6LMNA | |
| SCHEMBL8168317 | 1.00 | TSHR (0.35) | TSHRMEN1KMT2ACYP2D6LMNA | |
| SCHEMBL16492330 | 0.74 | MEN1 (0.35) | TSHRMEN1KMT2ACYP2D6LMNA | |
| SCHEMBL3319727 | 0.74 | CHRM2 (0.36) | TSHRCHRM3 | |
| SCHEMBL16492329 | 0.74 | MEN1 (0.35) | TSHRMEN1KMT2ACYP2D6LMNA | |
| SCHEMBL10808200 | 0.68 | CHRM3 (0.33) | MEN1KMT2ACYP2D6LMNAHRH1 | |
| SCHEMBL5001662 | 0.68 | EPHX1 (0.48) | TSHRCHRM3 | |
| SCHEMBL4992450 | 0.68 | EPHX1 (0.48) | TSHRCHRM3 | |
| SCHEMBL5668164 | 0.68 | EPHX1 (0.48) | TSHRCHRM3 | |
| SCHEMBL4992437 | 0.68 | EPHX1 (0.48) | TSHRCHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1341927-B1 | METHOD OF PREPARING 3-¬2-{(METHYLSULFONYL)OXY}ETHOXY|-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE | PPG IND OHIO INC (US) | 2006-08-02 | — | — | EP | disclosed |
| EP-1341927-A1 | METHOD OF PREPARING 3- 2- (METHYLSULFONYL)OXY ETHOXY]-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE | PPG Industries Ohio, Inc. (US) | 2003-09-10 | — | — | EP | disclosed |
| CN-1093759-C | Protein kinase C inhibitors | LILLY CO ELI (US) | 2002-11-06 | — | — | CN | disclosed |
| WO-2002059342-A1 | METHOD OF PREPARING 3-[2-{(METHYLSULFONYL)OXY}ETHOXY]-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE | PPG INDUSTRIES OHIO, INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| US-6300106-B1 | FORMING S-ISOMER OR R-ISOMER OF (3,6-DIHYDRO-2H-PYRAN-2-YL)-METHANOL VIA A PROCESS WHICH PRODUCES A RACEMIC MIXTURE OF INTERMEDIATE REACTION PRODUCTS, RESOLVING TO SELECTIVELY PRODUCE S ISOMER | PPG INDUSTRIES OHIO, INC. | 2001-10-09 | — | — | US | disclosed |
| US-6117861-A | USEFUL IN TREATING CONDITIONS ASSOCIATED WITH DIABETES MELLITUS AND ITS COMPLICATIONS, ISCHEMIA, INFLAMMATION, CENTRAL NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISEASE, DERMATOLOGICAL DISEASE AND CANCER | ELI LILLY AND COMPANY (US) | 2000-09-12 | — | — | US | disclosed |
| EP-0776899-B1 | Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides | LILLY CO ELI (US) | 2000-03-29 | — | — | EP | disclosed |
| US-6015807-A | NOVEL BIS-INDOLYLMALEIMIDE MACROCYCLE DERIVATIVES, PREPARING A SALT | ELI LILLY AND COMPANY (US) | 2000-01-18 | — | — | US | disclosed |
| EP-0657411-B1 | Synthesis of bisindolylmaleimides | LILLY CO ELI (US) | 1999-06-09 | — | — | EP | disclosed |
| CN-1202825-A | Protein kinase C inhibitor | LILLY CO ELI (US) | 1998-12-23 | — | — | CN | disclosed |
| US-5721272-A | PROTEIN KINASE C INHIBITORS | ELI LILLY AND COMPANY (US) | 1998-02-24 | — | — | US | disclosed |
| US-5710145-A | Protein kinase C inhibitor | ELI LILLY AND COMPANY (US) | 1998-01-20 | — | — | US | disclosed |
| US-5665877-A | Synthesis of bisindolylmaleimides | ELI LILLY AND COMPANY (US) | 1997-09-09 | — | — | US | disclosed |
| EP-0776899-A1 | Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides | ELI LILLY AND COMPANY (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0776895-A1 | Protein kinase C inhibitor | ELI LILLY AND COMPANY (US) | 1997-06-04 | — | — | EP | disclosed |
| WO-1997018809-A1 | PROTEIN KINASE C INHIBITOR | ELI LILLY AND COMPANY (US) | 1997-05-29 | — | — | WO | disclosed |
| WO-1997019080-A1 | NOVEL INTERMEDIATES AND THEIR USE TO PREPARE N,N'-BRIDGED BISINDOLYLMALEIMIDES | ELI LILLY AND COMPANY (US) | 1997-05-29 | — | — | WO | disclosed |
| US-5614647-A | Intermediates for the synthesis of bisindolylmaleimides | ELI LILLY AND COMPANY (US) | 1997-03-25 | — | — | US | disclosed |
| US-5541347-A | Synthesis of bisindolylmaleimides | ELI LILLY AND COMPANY (US) | 1996-07-30 | — | — | US | disclosed |
| EP-0657411-A1 | Improved synthesis of bisindolylmaleimides | ELI LILLY AND COMPANY (US) | 1995-06-14 | — | — | EP | disclosed |